The µTASWako i50 shows: high agreement with i30, improved throughput & automated dilution for high biomarker levels. What’s the biggest limitation in your current biomarker workflow?
Read more: www.cureus.com/articles/417...
#Cureus #MedSky #LabMedicine #CancerDiagnostics
Welcome to Issue 4! Please read the cover article:
Spatiotemporal identification of therapeutic markers 𝘷𝘪𝘢 dual-targeted #SERS bioprobes for assessing breast cancer progression by Xiaoxia Wu, Dong Xu, Aiguo Wu, Jie Lin 𝘦𝘵 𝘢𝘭.
#Free_to_read #BreastCancer #CancerDiagnostics
doi.org/10.1039/D5QM...
🧪 Liquid Biopsy — Jan 2026
• Post-treatment ctDNA predicts recurrence across multiple cancers
• Baseline mutation status refines prognosis in advanced disease
• CTCs and EV-derived signals guide therapy response
pir.sh/A5kgYmGg4m
#LiquidBiopsy #ctDNA #PrecisionOncology #CancerDiagnostics
Oncology diagnostics innovation drives the US Minimal Residual Disease Testing Market. Report: www.marketresearchfuture.com/reports/us-m...
#CancerDiagnostics
Early detection trends accelerate the US Cancer Diagnostics Market. Get AI-driven diagnostics insights: www.marketresearchfuture.com/reports/us-c...
#CancerDiagnostics #MedTech
The color wheel of #cancer #poop
msipressblog.blogspot.com/2026/02/canc...
#cancerdiagnostics #signsofcancer
🧬 Liquid Biopsy Testing Market is transforming cancer diagnostics with non-invasive testing solutions. Learn more 👉 www.marketresearchfuture.com/es/reports/i...
#CancerDiagnostics #IVD
Non-invasive cancer diagnostics are fueling the Liquid Biopsy Testing Market. 🧬🧪 www.marketresearchfuture.com/reports/in-v...
#CancerDiagnostics
Increasing prostate cancer screening is boosting the PSA Testing Market. 🎗️🧪 www.marketresearchfuture.com/reports/pros...
#CancerDiagnostics
🎗️ Early detection demand boosts the Ovarian Cancer Diagnostic Market. 📊 www.marketresearchfuture.com/reports/ovar... #CancerDiagnostics
🎯 Precision diagnostics fuel the Fusion Biopsy Market growth. 📈 www.marketresearchfuture.com/reports/fusi... #CancerDiagnostics
🩸🎗️ Advanced diagnostics expand the Hemato-Oncology Testing Market. 📈 www.marketresearchfuture.com/reports/hema... #CancerDiagnostics
How can next-generation cancer diagnostic tools reshape patient outcomes?
The Festival of Genomics and Biodata offers a chance to explore the full spectrum of the #cancerdiagnostics landscape.
Register now: hubs.la/Q03JMxrd0 #FOG2026
🎗️ The South America Circulating Tumor Cell Market supports early cancer detection & liquid biopsy innovation. Learn more. www.marketresearchfuture.com/reports/sout... #CancerDiagnostics
Precision prostate cancer diagnosis boosts growth in the Fusion Biopsy Market. 🎯 Read insights 👉 www.marketresearchfuture.com/reports/fusi... #CancerDiagnostics
Rising cancer diagnosis rates support the Biopsy Devices Market 🧫📈 Explore trends 👉 www.marketresearchfuture.com/reports/biop... #CancerDiagnostics #MedDevices
🧠 Early detection technologies drive expansion in the Brain Tumor Diagnostics Market. 📊🚀 Read 👉 www.marketresearchfuture.com/reports/brai... #CancerDiagnostics #Healthcare #MedTech
🔬 Biopsy Devices Market grows with rising cancer diagnostics demand worldwide. Explore market outlook 📊 www.marketresearchfuture.com/reports/biop... #CancerDiagnostics #MedicalDevices #Healthcare
Cancer Diagnostics Market to hit USD 269.1B by 2030 at 6.7% CAGR! Precision screening tech dominates growth. 🎯
www.globenewswire.com/en/news-rele...
#CancerDiagnostics
🔗 Read more: bit.ly/ONCOnews02D-2
#ONCOnews #OncoAlert #OncEd #OncologyNews #ProstateCancer #CancerDiagnostics #MedicalInnovation
🌍 Mark your calendars — Madrid awaits!
ISLB 2026 will be taking place Nov 7–9, 2026 in Madrid, Spain. Join leading scientists and clinicians to explore the latest advances in liquid biopsy and precision medicine.
#ISLB2026 #LiquidBiopsy #PrecisionMedicine #CancerDiagnostics
Detection of circulating tumor DNA in colorectal cancer patients using a methylation-specific droplet digital PCR multiplex
🔓 buff.ly/CG0J1Ck
#ctDNA #ddPCR #CRC #Epigenetics #CancerDiagnostics #Biomarkers
Join us today at #AMPath2025 for a 3PM workshop at 160B, Level 1 to learn how #DNBSEQ tech enables ultra-sensitive detection, scalable genomics, and precision diagnostics across applications.
www.completegenomics.com/events/amp-2...
#AMP2025 #AMP25 #Genomics #CancerDiagnostics #InfectiousDisease
🔗 Read more: bit.ly/ONCOnews12N-1
#ONCOnews #OncoAlert #OncEd #FDAApproval #EndometrialCancer #CancerDiagnostics
🤖 AI is accelerating #CancerDiagnostics - improving both speed and accuracy.
Learn more in the session “AI-based biomarkers for precision oncology” at #ESMOAI25 in Berlin.
👉 www.esmo.org/meeting-cale...
#DigitalOncology #PrecisionOncology #HealthAI
Early detection of liver cancer is challenging, that’s why IHC matters. Bio SB creates reliable #antibodies that help pathologists detect cancer sooner and more accurately
Find out more here: 🔗www.stratech.co.uk/b...
#pathology #IHC #diagnostics #CancerDiagnostics #pathologists #BIOSB
AI is revolutionizing cancer detection. The USPTO plans to grant bioAffinity Technologies a patent for our AI-powered flow cytometry platform that detects lung cancer with precision and consistency. Learn more: bit.ly/42N8CAq
#CyPathLung #cancerdiagnostics #patent #AI
Natasha Leighl, recipient of the 2025 ESMO Women for Oncology Award, will present her Award lecture at the #ESMO25 Opening Session. She will discuss key contributions to #LungCancer research & the role of liquid biopsy in #CancerDiagnostics.
📅 Opening Session https://ow.ly/BwMO50XavIS
✅ Interested in the latest in #cancer #liquidbiopsy, circulating tumor DNA ( #ctDNA), and #MRD testing? 🧪
I'll be a #panelist on a virtual #roundtable on October 22nd.
Signup below. Hosted by @genomeweb.bsky.social
event.on24.com/wcc/r/508470...
#oncology #bcsm #cancerdiagnostics #dPCR
In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome
www.newswise.com/articles/in-...
#Microbiome #cancer #cancerawareness #genomicsequencing #CancerDiagnostics